New method to differentiate between lupus anticoagulants, progressive coagulation inhibitors and coagulation factor deficiencies in the mixing tests

Daiki Shimomura,Osamu Kumano,Kaori Ueda,Keisuke Kitano,Nobuo Arai,Masashi Shimada,Mikio Kamioka

DOI: https://doi.org/10.1111/ijlh.14289

2024-04-22

International Journal of Laboratory Hematology

Abstract:Introduction Mixing tests in activated partial thromboplastin time (APTT) are used for the differentiation between lupus anticoagulants (LA), coagulation inhibitors, and factor deficient samples with APTT prolongation. However, the indexes for the differentiation have not been established. The present study aimed to develop new mixing test indexes for the differentiation. Methods Twenty‐six LA‐positive, 8 progressive coagulation factor VIII inhibitor, and 35 coagulation deficient samples were employed. APTT were measured for normal plasma, patient plasma, and mixing plasma prepared at a ratio of 1:1 proportion in both without incubation and 2 h‐incubation. New two parameters named as ALD50 and mixture plasma—patient plasma after Warming change rate Subtraction (WaS) calculated from the clotting times of normal, 1:1 mixing and patient samples with/without 2 h‐incubation were established. In the samples with WaS result of <10.2%, ALD50 of ≥87.8%, and

hematology